YOUR NAVICA APP QUESTIONS ANSWERED

Last Updated: SEP 3, 2020

WHAT IS NAVICA?

The NAVICA app is your pass to navigating daily life in a new normal. NAVICA displays results from the 15-minute Abbott BinaxNOW COVID-19 Ag Card, a rapid antigen test, to help you and others make informed decisions.

Organizations will be able to view and verify a person's digital NAVICA Pass on their mobile device to facilitate smoother entry into facilities along with handwashing, social distancing, enhanced cleaning and mask-wearing.

WHAT CAN I DO WITH THE NAVICA APP?

Organizations will be able to view and verify this pass to facilitate entry into facilities along with handwashing, social distancing, enhanced cleaning and mask-wearing.

With NAVICA you can:

  • Use your NAVICA ID at a NAVICA-enabled test site
  • View current and historical COVID-19 test results at any time
  • Receive a NAVICA Pass once the test site submits a negative test result

Visit NAVICA.ABBOTT to sign up to be one of the first to know when and where the COVID-19 tests are being offered in your community.

HOW CAN I GET THE NAVICA APP?

NAVICA, the first-of-its-kind app, can be downloaded from both the App Store and Google Play at no charge. Go to your app store and search NAVICA.

The NAVICA app is compatible with both Apple and Android smartphones. Operating system requirements are iOS 11 and above and Android 8 and above.

WHAT IS THE NAVICA PASS?

NAVICA will display a digital NAVICA Pass via a QR code, similar to an airline boarding pass, for the NAVICA user who has received a negative result from a NAVICA-enabled test site. This allows organizations to verify negative test results—enabling people to move about with greater confidence.

Getting a NAVICA pass is an easy 3-step process:

  1. Download the NAVICA App and create a secure profile.
  2. Show your profile’s unique ID when you get tested at a NAVICA-enabled test site.
  3. Receive a NAVICA Pass when you test negative for COVID-19 and your test provider submits your result.

HOW DO I FIND A NAVICA-ENABLED TEST CENTER?

Visit NAVICA.ABBOTT to sign up to be one of the first to know when and where the COVID-19 tests are being offered in your community.

WHAT KIND OF TEST IS USED TO GET A NAVICA PASS?

The BinaxNOW COVID-19 Ag Card is a rapid lateral flow antigen test administered by a healthcare professional or a trained operator. It tests for active infection using a direct nasal swab. It provides a positive or negative result in 15 minutes with no instrument required.

WHAT DOES IT COST TO DOWNLOAD THE NAVICA APP?

Abbott is offering the mobile app at no charge.

WHAT INFORMATION DO I HAVE TO SHARE TO GET NAVICA?

The information needed to create your NAVICA ID is First Name, Last Name, Zip Code, Email Address, Date of Birth and mobile phone number.

WHAT IF I DIDN’T RECEIVE MY VERIFICATION ID DURING APP REGISTRATION?

Check your email account junk mail or spam filters for email verification code. You can resend the email or chose a different email address during the sign-up process if you do not receive it.

HOW DO I RESET MY NAVICA PASSWORD?

You can change your password from the sign-in screen with the 'Forgot my password' link. You'll be asked to verify your email address again to proceed with changing your password.

I'M CREATING MY ACCOUNT ON AN ANDROID DEVICE AND HAVING TROUBLE SELECTING MY DATE OF BIRTH.

If you are on an Android device, you can set your birth year by tapping the year displayed in the upper left hand corner. Once year is set you can scroll to the select the appropriate month and day.

The BinaxNOW™ COVID-19 Ag Card EUA has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories. The test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

true
accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?